Sangamo Therapeutics (NASDAQ:SGMO) Earns Sell Rating from Analysts at StockNews.com
StockNews.com began coverage on shares of Sangamo Therapeutics (NASDAQ:SGMO – Free Report) in a research report sent to investors on Thursday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. SGMO has been the topic of several other research reports. Royal Bank of Canada reaffirmed a sector perform rating and set a $2.00 […]
More Stories
Kraft Heinz Company (NASDAQ:KHC) Shares Purchased by D.A. Davidson & CO.
D.A. Davidson & CO. boosted its position in Kraft Heinz Company (NASDAQ:KHC – Free Report) by 7.8% in the first...
Troll 2 on Netflix: Release Date, Plot, Cast & What to Expect
After the immense success of Troll in 2022, Netflix is set to release Troll 2 this 2025! The Troll team...
The Role of AI and IoT in Next-Gen Facility Management Solutions
What’s the sign of a well-run facility? For decades, this would have meant minimal downtime, and no service disruptions or...
Patricia Roche Net Worth, Career, and Her Role in The Beanie Bubble
Patricia Roche came into the limelight with her admirable role in Ty Warner’s Beanie Babies. Her contribution to Ty Inc.’s...
Cardinal Health, Inc. (NYSE:CAH) Shares Bought by Principal Financial Group Inc.
Principal Financial Group Inc. raised its position in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 5.3% in the 1st...
Calamos Advisors LLC Sells 8,240 Shares of Piper Sandler Companies (NYSE:PIPR)
Calamos Advisors LLC lessened its position in Piper Sandler Companies (NYSE:PIPR – Free Report) by 77.1% during the first quarter,...